SEC Form 4 · accession 0000920465-19-000009
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Rolke
Officer — Chief Scientific Officer
Period of report
Jan 9, 2019
Accepted (ET)
Jan 9, 2019 · 9:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2019 | P | 300 | $6.07 | A | 75,030 | D | |
| Common Stock | Jan 9, 2019 | P | 500 | $6.09 | A | 75,530 | D | |
| Common Stock | Jan 9, 2019 | P | 800 | $6.10 | A | 76,330 | D |
Table II — derivative securities
No Table II lines on this filing.